Prognostic Significance and Therapeutic Implications of CD34, an Angiogenic Marker, in Oral Squamous Cell Carcinoma: A Narrative Review

Head and neck cancer is the 7th most common malignancy worldwide. Few decades earlier, there has been an enormous rise in genetic events as the source in the development of Oral Squamous Cell Carcinoma (OSCC) and metastasis to various organs. The seeding of neoplastic cells occurs via blood vessels...

Full description

Saved in:
Bibliographic Details
Main Authors: Niva Mahapatra, S Nithya, Divya Uppala, Soundarya Srinivasan, Daffney Mano Doss
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2024-12-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://www.jcdr.net/articles/PDF/20367/74349_CE[Ra1]_F(SL)_QC(SD_IS)_PF1(RI_SS)_PFA(IS)_PN(IS).pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846128961869840384
author Niva Mahapatra
S Nithya
Divya Uppala
Soundarya Srinivasan
Daffney Mano Doss
author_facet Niva Mahapatra
S Nithya
Divya Uppala
Soundarya Srinivasan
Daffney Mano Doss
author_sort Niva Mahapatra
collection DOAJ
description Head and neck cancer is the 7th most common malignancy worldwide. Few decades earlier, there has been an enormous rise in genetic events as the source in the development of Oral Squamous Cell Carcinoma (OSCC) and metastasis to various organs. The seeding of neoplastic cells occurs via blood vessels (haematogenous spread), lymphatics (lymphogenous spread), or invasion into body cavities (transcoelomic spread). Neoangiogenesis results in haematogenous spread from the site of the primary tumour. Various angiogenic markers have been recognised, like Vascular Endothelial Growth Factor (VEGF), Angiopoietin-1 (Ang-1), Ang-2, Cluster of Differentiation (CD34), in head and neck neoplasms. The specificity and sensitivity of CD34 helps in vascular endothelial cell staining. CD34 is a type I transmembrane molecule of 110 kDa that is heavily glycosylated and expressed on haematopoietic progenitor cells selectively. The quantification of new blood vessels using CD34 antibody by Microvessel Density (MVD) can be used as a diagnostic and therapeutic indicator in many solid malignancies, like OSCC. Increased expression of positive CD34 antibody induces neoangiogenesis in neoplasms, upsurges the stemness of cancer and boosts its potential to metastasise. In this context, the present review focuses on use of CD34 antibody as a potential angiogenic marker that can be used to determine the the aggressiveness and potential outcome of the tumour based on the literature overview.
format Article
id doaj-art-3f024fc9d0b34381b4c88dfe84f3c88c
institution Kabale University
issn 2249-782X
0973-709X
language English
publishDate 2024-12-01
publisher JCDR Research and Publications Private Limited
record_format Article
series Journal of Clinical and Diagnostic Research
spelling doaj-art-3f024fc9d0b34381b4c88dfe84f3c88c2024-12-10T11:04:49ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2024-12-011812010410.7860/JCDR/2024/74349.20367Prognostic Significance and Therapeutic Implications of CD34, an Angiogenic Marker, in Oral Squamous Cell Carcinoma: A Narrative ReviewNiva Mahapatra0S Nithya1Divya Uppala2Soundarya Srinivasan3Daffney Mano Doss4Reader, Department of Oral and Maxillofacial Pathology, Kalinga Institute of Dental Sciences, Bhubaneswar, Odisha, India.Assistant Professor, Department of Oral and Maxillofacial Pathology, ESIC Dental College and Hospital, New Delhi, India.Professor and Head, Department of Oral and Maxillofacial Pathology, GITAM Dental College, Vizag, Andhra Pradesh, India.Reader, Department of Oral and Maxillofacial Pathology, Best Dental Science College and Hospital, Madurai, Tamil Nadu, India.Lecturer, Department of Oral and Maxillofacial Pathology, CSI College of Dental Sciences and Research, Madurai, Tamil Nadu, India.Head and neck cancer is the 7th most common malignancy worldwide. Few decades earlier, there has been an enormous rise in genetic events as the source in the development of Oral Squamous Cell Carcinoma (OSCC) and metastasis to various organs. The seeding of neoplastic cells occurs via blood vessels (haematogenous spread), lymphatics (lymphogenous spread), or invasion into body cavities (transcoelomic spread). Neoangiogenesis results in haematogenous spread from the site of the primary tumour. Various angiogenic markers have been recognised, like Vascular Endothelial Growth Factor (VEGF), Angiopoietin-1 (Ang-1), Ang-2, Cluster of Differentiation (CD34), in head and neck neoplasms. The specificity and sensitivity of CD34 helps in vascular endothelial cell staining. CD34 is a type I transmembrane molecule of 110 kDa that is heavily glycosylated and expressed on haematopoietic progenitor cells selectively. The quantification of new blood vessels using CD34 antibody by Microvessel Density (MVD) can be used as a diagnostic and therapeutic indicator in many solid malignancies, like OSCC. Increased expression of positive CD34 antibody induces neoangiogenesis in neoplasms, upsurges the stemness of cancer and boosts its potential to metastasise. In this context, the present review focuses on use of CD34 antibody as a potential angiogenic marker that can be used to determine the the aggressiveness and potential outcome of the tumour based on the literature overview.https://www.jcdr.net/articles/PDF/20367/74349_CE[Ra1]_F(SL)_QC(SD_IS)_PF1(RI_SS)_PFA(IS)_PN(IS).pdfcluster of differentiationhead and neck carcinomamalignancymetastasismicrovessel densityneoangiogenesis
spellingShingle Niva Mahapatra
S Nithya
Divya Uppala
Soundarya Srinivasan
Daffney Mano Doss
Prognostic Significance and Therapeutic Implications of CD34, an Angiogenic Marker, in Oral Squamous Cell Carcinoma: A Narrative Review
Journal of Clinical and Diagnostic Research
cluster of differentiation
head and neck carcinoma
malignancy
metastasis
microvessel density
neoangiogenesis
title Prognostic Significance and Therapeutic Implications of CD34, an Angiogenic Marker, in Oral Squamous Cell Carcinoma: A Narrative Review
title_full Prognostic Significance and Therapeutic Implications of CD34, an Angiogenic Marker, in Oral Squamous Cell Carcinoma: A Narrative Review
title_fullStr Prognostic Significance and Therapeutic Implications of CD34, an Angiogenic Marker, in Oral Squamous Cell Carcinoma: A Narrative Review
title_full_unstemmed Prognostic Significance and Therapeutic Implications of CD34, an Angiogenic Marker, in Oral Squamous Cell Carcinoma: A Narrative Review
title_short Prognostic Significance and Therapeutic Implications of CD34, an Angiogenic Marker, in Oral Squamous Cell Carcinoma: A Narrative Review
title_sort prognostic significance and therapeutic implications of cd34 an angiogenic marker in oral squamous cell carcinoma a narrative review
topic cluster of differentiation
head and neck carcinoma
malignancy
metastasis
microvessel density
neoangiogenesis
url https://www.jcdr.net/articles/PDF/20367/74349_CE[Ra1]_F(SL)_QC(SD_IS)_PF1(RI_SS)_PFA(IS)_PN(IS).pdf
work_keys_str_mv AT nivamahapatra prognosticsignificanceandtherapeuticimplicationsofcd34anangiogenicmarkerinoralsquamouscellcarcinomaanarrativereview
AT snithya prognosticsignificanceandtherapeuticimplicationsofcd34anangiogenicmarkerinoralsquamouscellcarcinomaanarrativereview
AT divyauppala prognosticsignificanceandtherapeuticimplicationsofcd34anangiogenicmarkerinoralsquamouscellcarcinomaanarrativereview
AT soundaryasrinivasan prognosticsignificanceandtherapeuticimplicationsofcd34anangiogenicmarkerinoralsquamouscellcarcinomaanarrativereview
AT daffneymanodoss prognosticsignificanceandtherapeuticimplicationsofcd34anangiogenicmarkerinoralsquamouscellcarcinomaanarrativereview